INTRODUCTION
Vascular complications are relevant causes of poor outcome for patient and allograft after pediatric liver transplantation (PLT) [1] [2] [3] [4] [5] . Among vascular complications of PLT hepatic artery thrombosis (HAT) and portal vein 753 October 27, 2018|Volume 10|Issue 10| WJH|www.wjgnet.com Nacoti M et al . Thrombosis in PLT thrombosis (PVT) are one of the most frequent [1] [2] [3] [4] [5] [6] [7] and serious causes of graft loss and also patient death [1, 2, [6] [7] [8] [9] . In particular HAT is an extremely serious complication resulting in bile duct necrosis and often requiring retransplantation [10, 11] . Thrombosis of other intra-abdominal vessels, such as the hepatic vein and inferior vena cava occurs less frequently [6, 11, 12] . In the first years of PLT the observed incidence of thrombosis was very high, up to 42% [13] [14] [15] . In the last years, an improvement of perioperative care has significantly decreased the thrombosis incidence [1] [2] [3] . More recently, an incidence rate of HAT ranging from 2% to 10% after liver transplantation in the pediatric population has been reported [1, 6, 7, 11] ; likewise, the incidence rate of PVT ranged from 2% to 10% [1, 6, 7, 9] . In this context, the prevention of HAT and PVT remains very important for PLT outcome and it should be a matter of primary interest for clinicians and researchers, considering the ongoing scarcity of hepatic allografts [1, 2, 11, 12, [16] [17] [18] . In clinical practice, there is not a standardized approach for thrombosis prevention in PLT. Different surgical techniques and pharmacological prophylaxis have been purposed in several studies [1, 5, 6, 12, 14, [19] [20] [21] [22] [23] [24] [25] [26] [27] . Therefore, we performed a systematic review of current literature about surgical and pharmacological prophylaxis for prevention of thrombosis after PLT to evaluate the current evidence available.
MATERIALS AND METHODS

Search strategy
The publications were selected through an electronic search of the MEDLINE and EMBASE and Cochrane Library (CENTRAL) databases up to March 2018. The search strategy used the following Medical Subject Headings (MeSH) and EMTREE terms and text words: ("liver transplantation"/exp OR "liver transplantation") AND ("thromboembolism"/exp OR "thromboembolism" OR "ischemia"/exp OR "ischemia" OR "vascular disease" /exp OR "vascular disease") AND ("prophylaxis"/exp OR "prophylaxis" OR "prevention"/exp OR "prevention")
In addition the references of the selected studies and two systematic reviews on thrombosis and PLT [11, 17] were screened to identify further relevant studies.
Two reviewers (Giulia Maria Ruggeri and Giovanna Colombo) performed an independent study selection, solving any disagreements through discussion and the opinion of a third reviewer (Mirco Nacoti). They obtained study characteristics like year of publication, design, study centre, patients' characteristics like number, mean age and gender, treatments and number of arterial and venous thrombotic complications.
The following criteria were needed in order to be considered potentially eligible for this systematic review: (1) phase Ⅲ randomized clinical trials or cohorts including case series with more than 10 patients undergoing elective PLT (age ranged from 0 to 18 years); and (2) reporting arterial and venous thrombosis as primary or secondary events in all different groups according to the used prophylaxis strategy. If data from a study were reported in several publications, data from the most recent paper were used. Studies describing less than 10 PLT/year were excluded as significant high mortality is associated with low volume center [28, 29] . Articles published before 1990 were also excluded because new developments in perioperative PLT have dramatically improved the survival [1] [2] [3] .
Risk of bias assessment
Although the evaluation of quality for observational studies is controversial [30] , Giulia Maria Ruggeri and Giovanna Colombo assessed the risk of bias using the following items for cohort studies: Type of study (prospective or retrospective); selection of the patients (consecutive or not); thrombosis as pre-specified outcome; quality of measurements (studies in which thrombotic events were measured in an objective way were considered higher quality than studies without these characteristics). A scoring system was put in place to identify the following two quality categories: Studies at low-risk of bias (4 points) and studies at high-risk of bias (≤ 3 points).
RESULTS
Results of the search strategy
The study process is presented in Figure 1 . A total of 560 publications (550 retrieved with the electronic search strategy and 10 by manually reviewing the reference lists of all retrieved articles) were identified. After reading their titles and abstracts 525 were excluded, according to inclusion and exclusion criteria. The remaining 35 publications were analyzed in full for detailed evaluation. Twenty-six papers were eliminated for the following reasons: Publication date before 1990 (n = 2), only abstract (n = 4), studies without a comparator group (n = 13) and studies (n = 7) which did not contain explicit data about pediatric thrombotic events.
Nine manuscripts [31] [32] [33] [34] [35] [36] [37] [38] [39] , which included a total of 1034 PLT in 991 subjects, were included in this systematic review ( Table 1) . None of the all included studies were at high risk of bias according to pre-defined requirements ( Table 2 ). In particular, no study were prospective, only 7 studies reported thrombosis as a pre-defined outcome, and 8 studies detailed how the diagnosis of thrombosis had been made. The poor quality and the heterogeneity of included studies did not allow us to perform a pooled analysis of results.
Incidence of the artery and PVT Table 1 shows detailed incidence of artery and PVT as reported in the included studies. Most studies reported a total incidence (early and late) of thrombosis. The incidence of PVT varies from 2% to 10% in pediatric living donor liver transplantation (LDLT) [37, 39] and from 33% in pediatric LDLT to 4% in pediatric deceased donor liver transplantation (DDLT) with reduced graft [33] . HAT is presented mostly in mixed LDLT and DDLT pediaRecords identified from database searching (n = 550)
Additional records identified through manually reviewing the references lists of all retrieved articles and of two published systematic reviews (n = 10)
Potentially relevant studies identified and screened for retrieval (n = 560)
Studies excluded after screening of their titles and abstracts, based on inclusion criteria (n = 525)
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Studies excluded after articles screening Publication date before 1990 (n = 2) Only abstract (n = 4) Studies without a comparator group (n = 13) Studies without data about thrombotic events (n = 7)
Studies included in the systematic review (n = 9) Figure 1 Flow-chart of study selection process.
Reference Country Population (n ) Study design Method used for diagnosis and follow-up duration Intervention Outcome Main results
Sabra et al [37] Japan 113 pediatric LDLT [31, 32, [34] [35] [36] 38] .
Screening protocol for thrombosis detection
Most of the studies used Doppler ultrasonography (US) as a first line diagnostic screening for thrombosis [32, 33, [35] [36] [37] [38] [39] ; frequency and duration of the screening is quite variable. Confirmation of the thrombosis detected by a second level diagnostic test, such as computer CT angiography, surgery or other methods is rarely specified [31] [32] [33] 37, 38] . Table 1 summarizes the main results of the studies analyzed. In LDLT there are four different modalities to perform portal vein anastomosis: (1) standard reconstruction with end to end anastomosis [37, 39] ; (2) reconstruction with anastomosis to the bifurcation of the recipient left and right vein [39] ; (3) reconstruction with anastomosis to the confluence of the recipient mesenteric vein [39] ; and (4) reconstruction with an interposition of vein graft [33, 37, 39] . The overall results of different techniques were similar. The choice of the type of reconstruction depended on the size (length and diameter) and quality of the portal vein and size mismatch between donor and recipient portal vein [33, 37, 39] . Millis et al [33] showed a low PVT incidence with reduced size liver transplant (RLT) [4% vs 33% with whole liver transplant (WLT) and native reconstructed vein, P < 0.005]; RLT was developed in attempt to resolve the mismatch size liver between donor and recipient and was applied to split liver transplantation and LDLT. Three different surgical procedures seemed to reduce HAT incidence: RLT with cadaveric left lobe [incidence 0% vs 29% with WLT, P < 0.05 [34] ]; aortic arterial anastomosis without graft interposition [incidence 6% vs 24% in celiac-hepatic artery anastomosis, P = 0.02 [36] ] and microsurgical hepatic arterial reconstruction (MHR) [incidence 0% vs conventional artery reconstruction, P = 0.006 [31] ]. López et al [32] and Yandza et al [35] did not find significant HAT difference between end-to-end anastomosis and aortohepatic interposition graft; Julka et al [38] showed that single hepatic artery reconstruction did not increase the HAT incidence in pediatric LDLT having dual hepatic arterial stump in the liver graft.
Intraoperative surgical prophylaxis
Post-operative pharmacological prophylaxis
No studies on pharmacological prophylaxis compared clinical outcomes according to different treatments used [1, 9, [11] [12] [13] 17, [22] [23] [24] 27] .
DISCUSSION
Vascular thrombotic complications were a serious lifethreatening complication in the first year of PLT with an incidence up to 42% associated with mortality up to 50% [13] [14] [15] . Although factors causing thrombotic complications are not fully understood [15] , a global improvement of perioperative care has significantly decreased the thrombosis incidence in the last 20 years [1] [2] [3] 6, 7, 9, 11] . Several retrospective studies without control group tried to identify factors for thrombosis; among them should be mentioned medical factors, such as administration of fresh frozen plasma, elevated hematocrit, protein C deficiency [1, 14, 40, 41] and surgical factors, such as cold ischemia time, technique of anastomosis, small vessel diameter, the use of aortic grafts, donor arterial anatomy and reconstruction [1, 7, 14, 31, 36] , but without any definitive 757 October 27, 2018|Volume 10|Issue 10| WJH|www.wjgnet.com conclusions.
Accordingly, the aim of this systematic review was to identify evidence based methods both surgical and pharmacological for the prevention of thrombosis after PLT. In this systematic review, we found no prospective studies and only 9 retrospective studies with a control group referred to surgical prevention.
RLT (with left lobe or segment of left lobe) [34] direct aortic anastomosis and MHR [31] seem the best surgical options for reducing thrombotic complications in PLT, but the impact of RLT and aortic anastomosis on HAT were not confirmed by Stevens [36] and López-Yandza [32, 35] respectively. MHR is an arterial reconstruction performed with an operating microscope; it was introduced by the Kyoto group for the fine graft arteries (less than 2 mm in diameter) in LDLT [42] . The amazing results of MHR (0 HAT in 28 PLT) [31] need to be confirmed in a larger clinical trial. It is worth noting that one of the most extensive studies about incidence and risk factors for vascular complication in liver transplantation was excluded from this systematic review because it included a mixed adult and pediatric population, without an appropriate control group [1] . Pharmacological prophylaxis is a relevant topic in PLT. Several studies [1, 9, [11] [12] [13] 17, [22] [23] [24] 26] reported their experience using different drugs, such as unfractionated heparin, low molecular weight heparin, vitamin K antagonist fresh frozen plasma, aspirin, dipyridamole, antithrombin concentrate, dextran 40, thrombin inhibitor, prostaglandin. Unfortunately, in these studies there was not a comparator group, necessary in order to achieve formal proof of efficacy and safety and according to the inclusion criteria of this systematic review. In this regard, for example, aspirin is one of the most extensive drugs used for HAT prevention [11, 14, 17] , but without formal evidence derived from prospective clinical trials.
The careful search of the literature and the inclusion of different types of studies are the main strengths of this review. Nevertheless, our study presents some weaknesses. First, the risk of thrombosis might have been underestimated because we assumed not all
Reference
Study design Consecutive enrolment Thrombosis as pre-defined outcome Methods use to the diagnosis of thrombosis
Shackleton et al [31] Retrospective Yes Yes, HAT Clinical grounds and angiography and/or surgical exploration for confirmation
López et al [32] Retrospective Yes No Doppler US and angiography for confirmation, post mortem second confirmation Millis et al [33] Retrospective Yes Yes, PVT Doppler US and angiography for confirmation Jurim et al [34] Retrospective Yes Yes, HAT Not reported Yandza et al [35] Retrospective Yes Yes, HAT Doppler US Stevens et al [36] Retrospective Yes Yes, HAT Doppler US Sabra et al [37] Retrospective Yes Yes, PVT Doppler US Julka et al [38] Retrospective Yes No Doppler US and angiography for confirmation Saad et al [39] Retrospective Yes Yes, PVT Doppler US authors systematically reported thrombotic events. Second, the description of methods for preventing vascular thromboses may be incomplete because only studies reporting the outcome were considered. Although, HAT and PVT incidence has decreased in the last decades [1] [2] [3] 6, 7, 9, 11] , they remain one of the more frequent and serious complications causing a poor outcome after PLT [1, 2] . Furthermore, the old question "thrombosis after PLT -a medical or surgical event?" [14] remains an unresolved issue. Concerning this, our systematic review of studies, in which different prophylaxis strategies were tested for the prevention of HAT and PVT failed to provide enough evidence for a definitive conclusion due to the poor quality of studies found [31] [32] [33] [34] [35] [36] [37] [38] [39] . However, our analysis emphasizes the need of developing well-designed clinical studies in order to correctly determine PLT-associated thrombosis risk and to define an evidence-based antithrombotic prophylactic strategy. The recent "single ventricle trial" [43] showed that randomized clinical trials are possible also in the pediatric surgery area.
ARTICLE HIGHLIGHTS
Research background
Hepatic artery thrombosis (HAT) and portal vein thrombosis (PVT) commonly occur after pediatric liver transplantation (PLT) that may cause graft loss and patient death. Different surgical techniques and pharmacological prophylaxis have been purposed in several studies; nevertheless, there is not a stan dardized approach for thrombosis prevention in PLT.
Research motivation
Prevention of HAT and PVT remains very important for PLT outcome and it should be a matter of primary interest for clinicians and researchers, con sidering the ongoing scarcity of hepatic allografts.
Research objective
We performed a systematic review of current literature about surgical and pharmacological prophylaxis for prevention of thrombosis after PLT to evaluate the current evidence available.
Research methods
Studies were identified by electronic search of MEDLINE, EMBASE and Cochrane Library (CENTRAL) databases until March 2018. We excluded from this review case report, small case series, commentaries, conference abstracts, papers which describe less than 10 pediatric liver transplants/year and articles published before 1990. Two reviewers performed an independent study selection, solving any disagreements through discussion and the opinion of a third reviewer.
Research results
Nine retrospective studies were included in this review. They showed the use of tailored surgical strategies might be useful to reduce thrombosis. We did not find eligible studies evaluating pharmacological prevention strategies. The overall quality of studies was poor. A pooled analysis of results from studies was not possible due to the retrospective design and heterogeneity of included studies.
Research conclusions
This systematic review in which different prophylaxis strategies were tested for the prevention of HAT and PVT failed to provide enough evidence for a definitive conclusion due to the poor quality of studies found.
